Cedars-Sinai Develops New Tools to Improve Pancreatic Cancer Patient Care
Cedars-SinaiCedars-Sinai Cancer investigators have used a unique precision medicine and artificial intelligence (AI) tool called the Molecular Twin Precision Oncology Platform to identify biomarkers that outperform the standard test for predicting pancreatic cancer survival.